NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.49

20 Dec
2024

0.000

OPEN

$5.49

0.000

HIGH

$5.54

2,494,623

LOW

$5.46

TARGET
$6.835 24.5% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 38.3 41.4 xxx
DPS (cps) xxx 29.0 28.3 xxx
EPS Growth xxx - 7.5% 8.0% xxx
DPS Growth xxx 3.6% - 2.6% xxx
PE Ratio xxx N/A 13.3 xxx
Dividend Yield xxx N/A 5.1% xxx
Div Pay Ratio(%) xxx 75.7% 68.3% xxx

Dividend yield today if purchased 3 years ago: 4.18%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 5.28

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 05/09 - ex-div 14c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx38.3
DPS All xxxxxxxxxxxxxxx29.0
Sales/Revenue xxxxxxxxxxxxxxx3,413.9 M
Book Value Per Share xxxxxxxxxxxxxxx212.5
Net Operating Cash Flow xxxxxxxxxxxxxxx257.1 M
Net Profit Margin xxxxxxxxxxxxxxx5.47 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx18.69 %
Return on Invested Capital xxxxxxxxxxxxxxx14.48 %
Return on Assets xxxxxxxxxxxxxxx8.67 %
Return on Equity xxxxxxxxxxxxxxx18.69 %
Return on Total Capital xxxxxxxxxxxxxxx21.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx109.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx8 M
Long Term Debt xxxxxxxxxxxxxxx299 M
Total Debt xxxxxxxxxxxxxxx307 M
Goodwill - Gross xxxxxxxxxxxxxxx371 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx275 M
Price To Book Value xxxxxxxxxxxxxxx3.46

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx48.6 M
Capex % of Sales xxxxxxxxxxxxxxx1.42 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx184 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,091 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

5

xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

13/11/2024

3

Neutral

$6.45

17.49%

A -$10m operating loss in New Zealand resulted from a sharp spike in claims utilisation in 2H FY24, explains Citi, causing management at nib Holdings to lower FY25 underlying operating profit (UOP) guidance.

Management stated the negative impact in New Zealand is temporary, due to a combination of higher pricing, cost savings, and moderation in claims inflation.

The target falls to $6.45 from $6.35. Neutral.

FORECAST
Citi forecasts a full year FY25 dividend of 28.00 cents and EPS of 42.40 cents.
Citi forecasts a full year FY26 dividend of 32.00 cents and EPS of 50.60 cents.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

14/11/2024

3

Neutral

$7.20

31.15%

Jarden notes nib Holdings' solid growth in the Australian Resident Health Insurance (ARHI) segment, with a 3.2% year-on-year increase in net policyholders as of Q1.

New Zealand operations remain a concern as ongoing inflationary pressures drove claims inflation over 15%, leading to an expected -$10m operating profit loss in H1 FY25, as the company's pricing strategy struggles to keep pace.

While net margin guidance for Australian Residents Health Insurance (ARHI) of 6-7% is reiterated, the broker conservatively positions FY25 underlying operating profit at the low end of the company's guidance range of $235-250m.

Longer-term EPS forecasts have been adjusted, with a -5% cut for FY25 and 1-4% upgrades for FY26-27 as Jarden remains cautious about inflation risks.

Jarden raises its target price to $7.20 from $6.85 and retains a Neutral rating.

FORECAST
Jarden forecasts a full year FY25 dividend of 27.00 cents and EPS of 40.00 cents.
Jarden forecasts a full year FY26 dividend of 28.00 cents and EPS of 42.50 cents.
Access Extra Coverage Research History >

NHF STOCK CHART

FNArena News on NHF

1
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
2
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View
3
Rudi’s View: In Santa We Trust (?)

Dec 05 2024 - Rudi's View
4
Rudi’s View: Trump Beneficiaries & TechOne

Nov 28 2024 - Rudi's View
5
Rudi’s View: The Importance Of ‘Quality’ Growth

Nov 21 2024 - Rudi's View

Latest Insurance News

1
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
2
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
3
Steadfast’s Long March

Jul 02 2024 - Australia
4
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
5
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
6
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
7
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
8
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia
9
Underlying Trends Positive For QBE Insurance

May 15 2023 - Australia
10
Rates Over Reinsurance For General Insurers 

Feb 01 2023 - Australia